- Subject index
The first volume to provide access to information on drug treatment systems from a wide cross-section of 20 countries, Drug Treatment Systems in an International Perspective examines the ways in which other counties from around the world have chosen to cope with the spread of illicit drugs. Now health planners and administrators, treatment professionals, researchers, and students can place the development of their own treatment systems in a wider context and can examine the extent to which that development shares common structural features with those of other countries and cultures. Following a comparative discussion of the various countries, the volume addresses four key issues: gender specific treatment, the politics of financing and evaluation, the private sector and state control, and exporting drug treatment ideologies. It provides a comparative and cross-cultural perspective on drug treatment approaches today and examines the influence of social, political, and economic forces on the treatment of drug addicts. In addition, the editors have included a handy glossary, which explains key terms unfamiliar to readers outside the particular country. Providing and interdisciplinary and cross-cultural perspective to drug treatment, Drug Treatment Systems in an International Perspective will be of interest academics, students, and professionals in psychology, especially those focusing on clinical psychology, addiction, dependency, and treatment. It will also be of great interest to public health planners and administrators.
Chapter 28: Equal Access with Optimum Costs: Issues of Financing and Managing Drug Treatment
Equal Access with Optimum Costs: Issues of Financing and Managing Drug Treatment
How to reduce the inequality in access to services between people of different socioeconomic groups and regions has long been an issue in the financing and management of health care. More recently, the steep rise in the cost of health care has also become a prominent issue, and its containment is considered more and more a matter of economic incentives in health care systems. The same issues are discussed in relation to drug treatment. Even countries that have achieved equal access to general health services find it very difficult to do so for high-quality drug treatment. Also, drug treatment has been considered ...